-
May 30, 2023 08:04 PM IST The three-day initial public offering (IPO) will conclude on June 8. The bidding for anchor investors will open on June 5, according to the red herring prospectus (RHP).
-
May 26, 2023 06:17 AM IST A daily round-up of the most interesting articles to help jump-start the day.
- May 25, 2023 02:07 PM IST
Kotak Mahindra Capital and Goldman Sachs are currently in advanced talks to be selected as financial advisors, with Kotak closely collaborating with the startup to determine the IPO's structure
- May 22, 2023 10:44 AM IST
With more than 74 percent stake in Tata Tech, Tata Motors can garner huge returns from the flotation of its subsidiary
- May 20, 2023 05:20 PM IST
The proposed reduction in timelines for listing and trading of shares will benefit both issuers as well as investors.
- May 19, 2023 01:41 PM IST
The firm has seen an improvement in financial performance with net and gross NPAs falling to 1.41 and 4.76 percent, respectively, for the financial year ended March 2023.
- May 17, 2023 05:26 PM IST
The issue will conclude on May 25 and shares of the company will be listed on NSE Emerge, the company said in a statement.
- May 09, 2023 11:06 AM IST
Mankind Pharma IPO: The company is almost entirely focussed in India. The domestic market contributed 97.60 percent to the company's revenue from operations in FY22
- May 08, 2023 12:52 PM IST
Geojit has come out with its report on Nexus Select Trust. The research firm has recommended to “ Subscribe ” the ipo in its research report as on May 06, 2023.
- May 08, 2023 09:23 AM IST
Cainiao Network Technology's initial public offering (IPO) plan comes after Alibaba flagged in late March it would split its business into six units and that most of them would explore capital raisings or market debuts to help fund future growth.
- May 08, 2023 07:14 AM IST
The IPO comprises a fresh issue of equity shares and an offer for sale of over 1.72 crore equity shares by promoters and other shareholders.
- May 04, 2023 04:31 PM IST
Mankind Pharma will make its debut on the BSE and NSE on May 8 as per the schedule.
- May 03, 2023 07:40 PM IST
The company, which got approval from Sebi in May 2022 to float the initial public offering (IPO), did not launch the issue amid weak market conditions. It had earlier filed its draft papers in February 2022.
- April 28, 2023 07:13 AM IST
In contrast, the SME market witnessed higher activity, having raised $82 million via 38 IPOs
- April 28, 2023 07:05 AM IST
Oyo, which refiled its draft red herring prospectus (DRHP) with the SEBI under the recently introduced pre-filing route in March 2023, was sitting on a cash reserve of around Rs 2,700 crore, according to the presentation.
- April 25, 2023 11:27 AM IST
The biggest IPO of 2023 so far in terms of issue size - Mankind Pharma IPO - opened for subscription on April 25. The total fundraising would be Rs 4,110 cr at the lower price band. It has established several differentiated brands in condoms, pregnancy detection, emergency contraceptives, etc. Here are the 10 key things you must know before applying for this IPO!
- April 25, 2023 09:45 AM IST
ICICI Direct has come out with its report on Mankind Pharma. The research firm has recommended to “ Subscribe ” the ipo in its research report as on April 24, 2023.
- April 24, 2023 06:23 PM IST
These companies had filed preliminary IPO papers with the regulator between March 2022 and December 2022.
- April 25, 2023 09:35 AM IST
Geojit has come out with its report on Mankind Pharma. The research firm has recommended to “ Subscribe ” the ipo in its research report as on April 21, 2023.
- April 19, 2023 09:18 AM IST
Read untold stories from the world of business and corridors of power
- April 19, 2023 07:12 AM IST
Apart from its popular Manforce Condoms, Prega News, and Unwanted-72 brands, Mankind Pharma has also established a range of consumer healthcare brands in categories such as antacid powders (Gas-O-Fast), vitamin and mineral supplements (Health OK brand), and anti-acne preparations (AcneStar brand), among others.
- April 19, 2023 06:35 AM IST
The main reason for the poor show was the tepid IPO market, which plunged to $84.4 million from $1 billion in Q1 of 2022.
- April 18, 2023 05:46 PM IST
The subdued market conditions and muted response to the IPO from investors barring QIBs may be key reasons for the pathetic performance of the stock.
- April 19, 2023 06:32 AM IST
The stock started off at Rs 431 on the BSE against issue price of Rs 436 per share, while the listing price on the NSE was Rs 436.
- April 24, 2023 06:27 AM IST
Mankind Pharma, India’s fourth largest pharmaceutical company in terms of domestic sales and second largest in terms of sales volume for the financial year 2022, will open for subscription on April 25 and close on April 27. The anchor bidding will start on 24 April.
